Close Menu

NEW YORK (GenomeWeb) – If they are ever to see large-scale adoption, point-of-care molecular diagnostics systems need to be rapid and easy to use, but also relatively inexpensive with a broad test menu. These constraints sometimes limit POC MDx developers to using sample types with an abundance of target and a simple matrix.

Now, a startup in Scotland hopes to provide instrument developers with a sound wave-based technology to help overcome the bottleneck of sample preparation, potentially enabling a broader variety of targets and sample types to be tested at a lower cost.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.

Politico reports President Donald Trump has signed the $2 trillion coronavirus relief package.

A new analysis finds that peer review improves the quality of preprints just a little bit, according to ScienceInsider.

In PLOS this week: epigenetic drug triggers anti-viral activity, viral diversity among individuals with HIV experiencing virological failure, and more.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.